- This topic has 1 reply, 1 voice, and was last updated 8 years, 5 months ago by
.
-
Posts
-
A team of researchers at Harvard, identified an anti-cancer potential for one of the active ingredients in cannabis, delta9-tetrahydrocannabinol (THC).
THC acts on pair of receptors, CB1 and CB2. The receptors are found in the brain and peripheral tissues; CB1 activation in the brain is responsible for the psychoactive effects of the drug, CB1 activation in the circulation causes a decrease in blood pressure, and CB2 is involved in modulating immune function.
It has also been noted that CB1 and CB2 receptors are present in biopsy samples from lung cancer patients and from lung cancer cell lines. In this current study, the researchers found that treatment with THC inhibited growth in these cell lines, and also reduced tumor size and weight in a mouse model of lung cancer.
The science for the use of medicinal cannabis oil is credible, specific fact-based, and is documented in detail. There is absolutely no reason to not legalize medicinal cannabis and create an immediate production and distribution of high THC hash oil to cancer all sufferers.
- You must be logged in to reply to this topic.